Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Bank of Japan: Japanese companies expect consumer prices to rise by 2.3% in three years, compared with 2.3% in the previous survey; Japanese companies expect consumer prices to rise by 2.2% in five years, compared with 2.2% in the last survey.South Korea will take additional market stabilization measures when necessary.
Futures on the Nikkei Stock Exchange of Singapore opened down 175 points to 39,635.Bank of Japan: The confidence index of large manufacturers rose to the highest level since March 2022.The American medical insurance giant said that the suspect who assassinated its CEO was not a company customer. A spokesman for UnitedHealth Group said that Luigi Mangione, the suspect accused of killing Brian Thompson, CEO of the company's United Health Care, was not a member of the company's insurance plan. Unitedhealth group said that Man Ghione and his mother were not members of United Health Insurance Company, and refuted the claim that the shooting incident was caused by dissatisfaction caused by his special experience in the company.
Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.Luxury car dealers "switch to" domestic brands, and the competition between new and old forces spread to the channel side. Recently, Beijing Huayang Aotong Automobile Sales Co., Ltd. (referred to as "Huayang Aotong") announced that "the company will no longer continue the distribution business of Audi brands, but will continue to engage in the maintenance business of Audi models". On December 12, the reporter went to Huayang Aotong in Laiguangying, Beijing. The above announcement was posted at the entrance, and the store has been replaced with the "AITO" logo. There is no Audi car in the store, and it has been replaced by two models for sale in the world. A luxury brand dealer who did not want to be named revealed to reporters that Huayang Aotong had indeed been cancelled by Audi, and Zhengzhou Zhongsheng Huidi Store was also withdrawn from the network with it, all because it switched to Huawei's channel network without permission. "The war between new forces and traditional car companies has burned from the product side to the channel side." According to Zhang Xiuyang, secretary-general of China Passenger Car Industry Alliance, the "price war" that lasted for nearly two years has made it difficult for car dealers who are in retail terminals and have been upside down all the year round, and their loyalty has also declined. At the same time, in the tide of the era of smart cars, the concept of consumption is changing rapidly, and the high-end electric vehicle brands in China are gradually winning the wide favor of the market and consumers. (Securities Daily)Xiaomi Automobile is speeding up its voyage to sea, and will carry out automobile sales business in many regions. According to 36Kr, it is learned from many sources that Xiaomi is preparing to build automobile voyage business. Under the international department of the Group, Xiaomi has added a preparatory group for overseas sales business, and positions such as market research, project management and after-sales engineer of electric vehicles are being recruited. Under the Ministry of Automobile, Xiaomi's autonomous driving department has added a number of jobs for overseas markets to solve the problem of overseas legal verification and function landing of autonomous driving function. It is foreseeable that autonomous driving will be one of the key points of Xiaomi Automobile's betting on the sea. According to people familiar with the matter, after the formation of the team, Xiaomi will carry out small-batch car sales in many overseas regions, test the market reaction, and prepare for the large-scale development of sea business.